Our observation on the small proportion of bFGF-expressing DCIS specimens strongly contrasts reports on a higher rate (44%) of bFGF expression in invasive breast carcinomas (De Jong et al, 1998a). This evidence concerns the gene FGF2 and ductal breast carcinoma in situ.